OpenBilldrug price receipt

NADAC week of 2026-10-14

BUSPIRONE HCL 15 MG TABLET

For 30 tablets

Pharmacies pay

$1.29 filed

30 × $0.04296 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$4.39 filed

30 × $0.14647 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.4× estimated

Medicare paid 3.4× what pharmacies pay.

Part D averages every strength and form sold under “Buspirone HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.48 estimated

$1.29 + $0.19 (15%) + $5.00 fee per fill = $6.48

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BUSPIRONE HCL 15 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as buspirone hydrochloride, under the trade name “busPIRone HCl”.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 16 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Major Pharmaceuticals.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 41 NDCs (National Drug Codes); the FDA directory lists 38 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.29 for 30 tablets (30 × $0.04296 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 16 labelers

LabelerNDCsPharmacies pay per unit
Unichem Pharmaceuticals (USA), Inc.8$0.04296 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.4$0.04296 per EA filed
APNAR PHARMA LP3$0.04296 per EA filed
Advagen Pharma Ltd3$0.04296 per EA filed
AiPing Pharmaceutical, Inc.3$0.04296 per EA filed
Oxford Pharmaceuticals, LLC3$0.04296 per EA filed
Aurobindo Pharma Limited2$0.04296 per EA filed
Strides Pharma Science Limited2$0.04296 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.04296 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.04296 per EA filed
American Health Packaging1$0.04296 per EA filed
AvPAK1$0.04296 per EA filed
Major Pharmaceuticals1$0.04296 per EA filed
Mylan Institutional Inc.1$0.04296 per EA filed
Mylan Pharmaceuticals Inc.1$0.04296 per EA filed
Strides Pharma Inc.1$0.04296 per EA filed
Not listed as a package in the FDA directory3$0.04296 per EA filed

When these prices took effect

All 41 NDCs, with labeler and price
  • 00093-1003-01 · Teva Pharmaceuticals USA, Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 00093-1003-05 · Teva Pharmaceuticals USA, Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 00378-1165-05 · Mylan Pharmaceuticals Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 00904-6899-61 · Major Pharmaceuticals · $0.04296 per EA · eff. 2026-09-23 filed
  • 11788-0060-01 · AiPing Pharmaceutical, Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 11788-0060-03 · AiPing Pharmaceutical, Inc. · $0.04296 per EA · eff. 2026-10-07 filed
  • 11788-0060-05 · AiPing Pharmaceutical, Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 23155-0025-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 23155-0025-05 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 23155-0025-06 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 23155-0025-08 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 24689-0921-01 · APNAR PHARMA LP · $0.04296 per EA · eff. 2026-09-23 filed
  • 24689-0921-05 · APNAR PHARMA LP · $0.04296 per EA · eff. 2026-09-23 filed
  • 24689-0921-06 · APNAR PHARMA LP · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0246-01 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0246-05 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0246-16 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0246-18 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0477-01 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0477-05 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0477-16 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 29300-0477-18 · Unichem Pharmaceuticals (USA), Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 42543-0743-18 · Strides Pharma Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 50268-0135-11 · not listed as a package in the FDA directory · $0.04296 per EA · eff. 2026-09-23 filed
  • 50268-0135-15 · AvPAK · $0.04296 per EA · eff. 2026-09-23 filed
  • 51079-0960-01 · not listed as a package in the FDA directory · $0.04296 per EA · eff. 2026-09-23 filed
  • 51079-0960-20 · Mylan Institutional Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 59651-0392-01 · Aurobindo Pharma Limited · $0.04296 per EA · eff. 2026-09-23 filed
  • 59651-0392-05 · Aurobindo Pharma Limited · $0.04296 per EA · eff. 2026-09-23 filed
  • 60687-0823-01 · American Health Packaging · $0.04296 per EA · eff. 2026-09-23 filed
  • 60687-0823-11 · not listed as a package in the FDA directory · $0.04296 per EA · eff. 2026-09-23 filed
  • 64380-0743-03 · Strides Pharma Science Limited · $0.04296 per EA · eff. 2026-09-23 filed
  • 64380-0743-18 · Strides Pharma Science Limited · $0.04296 per EA · eff. 2026-09-23 filed
  • 68382-0182-01 · Zydus Pharmaceuticals USA Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 68382-0182-05 · Zydus Pharmaceuticals USA Inc. · $0.04296 per EA · eff. 2026-09-23 filed
  • 69584-0093-06 · Oxford Pharmaceuticals, LLC · $0.04296 per EA · eff. 2026-09-23 filed
  • 69584-0093-10 · Oxford Pharmaceuticals, LLC · $0.04296 per EA · eff. 2026-09-23 filed
  • 69584-0093-50 · Oxford Pharmaceuticals, LLC · $0.04296 per EA · eff. 2026-09-23 filed
  • 72888-0065-01 · Advagen Pharma Ltd · $0.04296 per EA · eff. 2026-09-23 filed
  • 72888-0065-05 · Advagen Pharma Ltd · $0.04296 per EA · eff. 2026-09-23 filed
  • 72888-0065-60 · Advagen Pharma Ltd · $0.04296 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name buspirone hydrochloride with BUSPIRONE HCL 15 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BUSPIRONE HCL 5 MG TABLET
generic · tablet
$0.02195 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.14647 per EA filed
Part D 2024 average
BUSPIRONE HCL 7.5 MG TABLET
generic · tablet
$0.1003 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.14647 per EA filed
Part D 2024 average
BUSPIRONE HCL 10 MG TABLET
generic · tablet
$0.02795 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.14647 per EA filed
Part D 2024 average
BUSPIRONE HCL 15 MG TABLET this page
generic · tablet
$0.04296 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.14647 per EA filed
Part D 2024 average
BUSPIRONE HCL 30 MG TABLET
generic · tablet
$0.11985 per EA filed
eff. 2026-09-23
$0.14647 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $4.39 for 30 tablets, at an average of $0.14647 per EA in 2024 (2024-01-01 to 2024-12-31) for “Buspirone HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 7,847,445 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for BUSPIRONE HCL 15 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Buspirone HCl / Buspirone HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.